Emmaus Life Sciences (EMMA) Payables (2010 - 2026)
Emmaus Life Sciences (EMMA) reported Payables of $40.8 million for Q2 2026, up 12.8% from $36.18 million a year earlier but down 2.5% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences posted Payables of $40 million, up 17.8% from FY2024.
- Payables has increased for five consecutive years, with a five-year compound annual growth rate of 39.4% (FY2020 to FY2025).
- By year, Payables came in at $33.94 million in FY2024 (+1.8%), $33.33 million in FY2023 (+18.2%), $28.2 million in FY2022 (+45.8%) and $19.35 million in FY2021 (+154.8%).
- Five-year quarterly Payables spans a low of $7.37 million in Q3 2021 and a high of $41.84 million in Q1 2026.
- Year over year, Payables has now increased in each of the last 19 quarters, with growth averaging 8.9% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q2 2022 (growth of 287.1%); the low point was Q3 2021 (a decline of 13.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $41.84 million (Q1 2026), $40 million (Q4 2025) and $38.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.78 Bn | 1,135.37 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 635.34 Bn | 553.86 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.48 Bn | 476.60 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 377.08 Bn | 331.46 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 304.13 Bn | 268.12 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.48 Bn | 241.16 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.75 Bn | 197.15 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.09 Bn | 168.29 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | 40.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.80 Mn |
| Mar 31, 2026 | 41.84 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Sep 30, 2025 | 38.56 Mn |
| Jun 30, 2025 | 36.18 Mn |
| Mar 31, 2025 | 35.18 Mn |
| Dec 31, 2024 | 33.94 Mn |
| Sep 30, 2024 | 34.91 Mn |
| Jun 30, 2024 | 35.25 Mn |
| Mar 31, 2024 | 34.78 Mn |
| Dec 31, 2023 | 33.33 Mn |
| Sep 30, 2023 | 33.00 Mn |
| Jun 30, 2023 | 29.51 Mn |
| Mar 31, 2023 | 29.11 Mn |
| Dec 31, 2022 | 28.20 Mn |
| Sep 30, 2022 | 25.48 Mn |
| Jun 30, 2022 | 24.78 Mn |
| Mar 31, 2022 | 20.29 Mn |
| Dec 31, 2021 | 19.35 Mn |
| Sep 30, 2021 | 7.37 Mn |
API Access
Emmaus Life Sciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();